1 Article by Jeehye Jung
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) – March 20, 2025
Summary
Psychedelic drugs like psilocybin and LSD show promise as innovative treatments for mental disorders such as depression and anxiety. By leveraging artificial intelligence and deep learning, researchers are uncovering how these substances interact with the brain’s transcriptome. This approach enhances drug development, paving the way for tailored therapies that could revolutionize mental health care.
Abstract
Mental disorders are a representative type of brain disorder, including anxiety, major depressive depression (MDD), and autism spectrum disorder (A...